21 May 2009
Memory and executive functions in patients after transplantation treated with different immunosuppressive drugs
L Gawryś, G Senatorski, L Pączek, L KaczmarekAnn Transplant 2009; 14(1): 75-75 :: ID: 880475
Abstract
Background: Rapamycin (Sirolimus) is an immunosuppressive drug used in
pharmacotherapy of patients after transplantation. The aim of the study was to investigate memory of patients after transplantation, which undergo the immunosuppressive pharmacotherapy with rapamycin. Rapamycin inhibits mTOR protein kinase, which is one of the key regulators of translational capacity. It was repeatedly shown that mTOR kinase is involved in synaptic plasticity mechanisms and long term memory formation.
Material/Methods: This study examined memory functions in three groups of patients after transplantation taking different immunosuppressive drugs: rapamycin (n=18), cyclosporine (n=15), mycophenolate mofetil (n=18) and group of 19 control subjects. Two procedural (Mirror Reading and Serial Reaction Task) and one declarative task (Auditory Verbal Learning Test) were employed in order to measure acquisition and retention of information. Since memory performance may be reduced owing to executive dysfunction, four measures of cognitive control were included in the study: Trial Making Test, Stroop Test, Wisconsin Card Sorting Test and Digit Span.
Results: The performance of memory tasks and tests of executive function did not differ in the three patients groups and there was no effect of immunosuppressive treatment used. No decrease of memory and executive function was found in patients after transplantation in comparison with the
healthy control subjects.
Conclusions: Immunosuppressive therapy had no effect on cognitive functions in studied patients group.
Keywords: Immunosuppression
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860